Eric Wallenstein

Eric Wallenstein has extensive experience in regulatory affairs and pharmaceutical development, currently serving as Senior Director of CMC Regulatory Affairs at Asklepios BioPharmaceutical, Inc. Previously, Eric held the position of Director of Global Regulatory CMC at both Bristol-Myers Squibb and Celgene. Prior roles also include Associate Director and Tech Transfer Lead at Merck, as well as Associate Principal Scientist, and Research Scientist at Centocor/Johnson & Johnson. Eric's background encompasses leadership in regulatory compliance and technical transfer within the biopharmaceutical industry.